BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 24121966)

  • 1. Candidate blood proteome markers of Alzheimer's disease onset and progression: a systematic review and replication study.
    Kiddle SJ; Sattlecker M; Proitsi P; Simmons A; Westman E; Bazenet C; Nelson SK; Williams S; Hodges A; Johnston C; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Newhouse S; Lovestone S; Dobson RJ
    J Alzheimers Dis; 2014; 38(3):515-31. PubMed ID: 24121966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology.
    Sattlecker M; Kiddle SJ; Newhouse S; Proitsi P; Nelson S; Williams S; Johnston C; Killick R; Simmons A; Westman E; Hodges A; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; ; Dobson RJ
    Alzheimers Dement; 2014 Nov; 10(6):724-34. PubMed ID: 24768341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multivariate protein signatures of pre-clinical Alzheimer's disease in the Alzheimer's disease neuroimaging initiative (ADNI) plasma proteome dataset.
    Johnstone D; Milward EA; Berretta R; Moscato P;
    PLoS One; 2012; 7(4):e34341. PubMed ID: 22485168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteome-based plasma biomarkers for Alzheimer's disease.
    Hye A; Lynham S; Thambisetty M; Causevic M; Campbell J; Byers HL; Hooper C; Rijsdijk F; Tabrizi SJ; Banner S; Shaw CE; Foy C; Poppe M; Archer N; Hamilton G; Powell J; Brown RG; Sham P; Ward M; Lovestone S
    Brain; 2006 Nov; 129(Pt 11):3042-50. PubMed ID: 17071923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A candidate plasma protein classifier to identify Alzheimer's disease.
    Zhao X; Lejnine S; Spond J; Zhang C; Ramaraj TC; Holder DJ; Dai H; Weiner R; Laterza OF
    J Alzheimers Dis; 2015; 43(2):549-63. PubMed ID: 25114072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.
    Westwood S; Baird AL; Anand SN; Nevado-Holgado AJ; Kormilitzin A; Shi L; Hye A; Ashton NJ; Morgan AR; Bos I; Vos SJB; Baker S; Buckley NJ; Ten Kate M; Scheltens P; Teunissen CE; Vandenberghe R; Gabel S; Meersmans K; Engelborghs S; De Roeck EE; Sleegers K; Frisoni GB; Blin O; Richardson JC; Bordet R; Molinuevo JL; Rami L; Wallin A; Kettunen P; Tsolaki M; Verhey F; Lléo A; Sala I; Popp J; Peyratout G; Martinez-Lage P; Tainta M; Johannsen P; Freund-Levi Y; Frölich L; Dobricic V; Legido-Quigley C; Bertram L; Barkhof F; Zetterberg H; Morgan BP; Streffer J; Visser PJ; Lovestone S
    J Alzheimers Dis; 2020; 74(1):213-225. PubMed ID: 31985466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are blood-based protein biomarkers for Alzheimer's disease also involved in other brain disorders? A systematic review.
    Chiam JT; Dobson RJ; Kiddle SJ; Sattlecker M
    J Alzheimers Dis; 2015; 43(1):303-14. PubMed ID: 25096613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticle-Enabled Enrichment of Longitudinal Blood Proteomic Fingerprints in Alzheimer's Disease.
    Hadjidemetriou M; Rivers-Auty J; Papafilippou L; Eales J; Kellett KAB; Hooper NM; Lawrence CB; Kostarelos K
    ACS Nano; 2021 Apr; 15(4):7357-7369. PubMed ID: 33730479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.
    Hampel H; Bürger K; Teipel SJ; Bokde AL; Zetterberg H; Blennow K
    Alzheimers Dement; 2008 Jan; 4(1):38-48. PubMed ID: 18631949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood Protein Markers of Neocortical Amyloid-β Burden: A Candidate Study Using SOMAscan Technology.
    Voyle N; Baker D; Burnham SC; Covin A; Zhang Z; Sangurdekar DP; Tan Hehir CA; Bazenet C; Lovestone S; Kiddle S; Dobson RJ;
    J Alzheimers Dis; 2015; 46(4):947-61. PubMed ID: 25881911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing candidate serum biomarkers for Alzheimer's disease: a longitudinal study.
    Zabel M; Schrag M; Mueller C; Zhou W; Crofton A; Petersen F; Dickson A; Kirsch WM
    J Alzheimers Dis; 2012; 30(2):311-21. PubMed ID: 22426016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replication study of plasma proteins relating to Alzheimer's pathology.
    Shi L; Winchester LM; Westwood S; Baird AL; Anand SN; Buckley NJ; Hye A; Ashton NJ; Bos I; Vos SJB; Kate MT; Scheltens P; Teunissen CE; Vandenberghe R; Gabel S; Meersmans K; Engelborghs S; De Roeck EE; Sleegers K; Frisoni GB; Blin O; Richardson JC; Bordet R; Molinuevo JL; Rami L; Wallin A; Kettunen P; Tsolaki M; Verhey F; Lléo A; Sala I; Popp J; Peyratout G; Martinez-Lage P; Tainta M; Johannsen P; Freund-Levi Y; Frölich L; Dobricic V; Legido-Quigley C; Barkhof F; Andreasson U; Blennow K; Zetterberg H; Streffer J; Lill CM; Bertram L; Visser PJ; Kolb HC; Narayan VA; Lovestone S; Nevado-Holgado AJ
    Alzheimers Dement; 2021 Sep; 17(9):1452-1464. PubMed ID: 33792144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large-scale plasma proteomic profiling identifies a high-performance biomarker panel for Alzheimer's disease screening and staging.
    Jiang Y; Zhou X; Ip FC; Chan P; Chen Y; Lai NCH; Cheung K; Lo RMN; Tong EPS; Wong BWY; Chan ALT; Mok VCT; Kwok TCY; Mok KY; Hardy J; Zetterberg H; Fu AKY; Ip NY
    Alzheimers Dement; 2022 Jan; 18(1):88-102. PubMed ID: 34032364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma protein profiling for potential biomarkers in the early diagnosis of Alzheimer's disease.
    Kitamura Y; Usami R; Ichihara S; Kida H; Satoh M; Tomimoto H; Murata M; Oikawa S
    Neurol Res; 2017 Mar; 39(3):231-238. PubMed ID: 28107809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma Proteomic Profiles of Cerebrospinal Fluid-Defined Alzheimer's Disease Pathology in Older Adults.
    Dayon L; Wojcik J; Núñez Galindo A; Corthésy J; Cominetti O; Oikonomidi A; Henry H; Migliavacca E; Bowman GL; Popp J
    J Alzheimers Dis; 2017; 60(4):1641-1652. PubMed ID: 29125490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer's disease.
    Wang H; Dey KK; Chen PC; Li Y; Niu M; Cho JH; Wang X; Bai B; Jiao Y; Chepyala SR; Haroutunian V; Zhang B; Beach TG; Peng J
    Mol Neurodegener; 2020 Jul; 15(1):43. PubMed ID: 32711556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic plasma protein panel for Aβ deposition in the brain in Alzheimer's disease.
    Park JC; Han SH; Lee H; Jeong H; Byun MS; Bae J; Kim H; Lee DY; Yi D; Shin SA; Kim YK; Hwang D; Lee SW; Mook-Jung I
    Prog Neurobiol; 2019 Dec; 183():101690. PubMed ID: 31605717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasensitive detection of blood biomarkers of Alzheimer's and Parkinson's diseases: a systematic review.
    Singh K; Cheung BM; Xu A
    Biomark Med; 2021 Dec; 15(17):1693-1708. PubMed ID: 34743546
    [No Abstract]   [Full Text] [Related]  

  • 19. Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology.
    Shi L; Winchester LM; Liu BY; Killick R; Ribe EM; Westwood S; Baird AL; Buckley NJ; Hong S; Dobricic V; Kilpert F; Franke A; Kiddle S; Sattlecker M; Dobson R; Cuadrado A; Hye A; Ashton NJ; Morgan AR; Bos I; Vos SJB; Ten Kate M; Scheltens P; Vandenberghe R; Gabel S; Meersmans K; Engelborghs S; De Roeck EE; Sleegers K; Frisoni GB; Blin O; Richardson JC; Bordet R; Molinuevo JL; Rami L; Wallin A; Kettunen P; Tsolaki M; Verhey F; Lleó A; Alcolea D; Popp J; Peyratout G; Martinez-Lage P; Tainta M; Johannsen P; Teunissen CE; Freund-Levi Y; Frölich L; Legido-Quigley C; Barkhof F; Blennow K; Rasmussen KL; Nordestgaard BG; Frikke-Schmidt R; Nielsen SF; Soininen H; Vellas B; Kloszewska I; Mecocci P; Zetterberg H; Morgan BP; Streffer J; Visser PJ; Bertram L; Nevado-Holgado AJ; Lovestone S
    J Alzheimers Dis; 2020; 77(3):1353-1368. PubMed ID: 32831200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.
    Wilcock D; Jicha G; Blacker D; Albert MS; D'Orazio LM; Elahi FM; Fornage M; Hinman JD; Knoefel J; Kramer J; Kryscio RJ; Lamar M; Moghekar A; Prestopnik J; Ringman JM; Rosenberg G; Sagare A; Satizabal CL; Schneider J; Seshadri S; Sur S; Tracy RP; Yasar S; Williams V; Singh H; Mazina L; Helmer KG; Corriveau RA; Schwab K; Kivisäkk P; Greenberg SM;
    Alzheimers Dement; 2021 Apr; 17(4):704-715. PubMed ID: 33480172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.